Maverick Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,600
| Closed | -$414K | – | 423 |
|
|
2023
Q4 | $414K | Buy |
+1,600
| New | +$414K | 0.01% | 221 |
|
|
2023
Q3 | – | Sell |
-983
| Closed | -$280K | – | 323 |
|
|
2023
Q2 | $280K | Buy |
+983
| New | +$280K | 0.01% | 358 |
|
|
2021
Q4 | – | Sell |
-3,112
| Closed | -$881K | – | 346 |
|
|
2021
Q3 | $881K | Buy |
+3,112
| New | +$881K | 0.01% | 335 |
|
|
2020
Q4 | – | Sell |
-1,436
| Closed | -$407K | – | 680 |
|
|
2020
Q3 | $407K | Sell |
1,436
-3,065
| -68% | -$869K | 0.01% | 436 |
|
|
2020
Q2 | $1.2M | Buy |
+4,501
| New | +$1.2M | 0.03% | 282 |
|
|
2019
Q4 | – | Sell |
-4,919
| Closed | -$1.15M | – | 352 |
|
|
2019
Q3 | $1.15M | Buy |
+4,919
| New | +$1.15M | 0.02% | 265 |
|
|
2017
Q3 | – | Sell |
-15,230
| Closed | -$4.13M | – | 186 |
|
|
2017
Q2 | $4.13M | Buy |
15,230
+5,620
| +58% | +$1.53M | 0.05% | 46 |
|
|
2017
Q1 | $2.63M | Sell |
9,610
-1,270
| -12% | -$347K | 0.03% | 90 |
|
|
2016
Q4 | $3.09M | Buy |
10,880
+500
| +5% | +$142K | 0.04% | 77 |
|
|
2016
Q3 | $3.25M | Sell |
10,380
-630
| -6% | -$197K | 0.04% | 47 |
|
|
2016
Q2 | $2.66M | Buy |
11,010
+1,640
| +18% | +$397K | 0.04% | 76 |
|
|
2016
Q1 | $2.44M | Buy |
+9,370
| New | +$2.44M | 0.04% | 56 |
|